A
Apogee Therapeutics
APGE · NASDAQ · Healthcare
$134.84
+$0.35 (+0.26%) today
Loading live data...
Market Cap
$10.20B
24h Volume
$200.7M
P/E Ratio
0.0
52w High
$134.84
52w Low
$34.65
Est. AI Revenue
80%
Loading chart data...
7-Day Sparkline (Static)
About Apogee Therapeutics
Clinical-stage biotech using AI-guided antibody engineering for atopic dermatitis and inflammatory diseases with computationally optimized biologics.
CEO: Michael Henderson
Founded: 2022
HQ: San Francisco, California
Employees: 261
Performance
24 Hours+0.26%
7 Days+0.56%
30 Days+0.95%
1 Year+281.01%